Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-12-19

Clinical Trial Update: Interferon Alfa in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia [Phase 3]

View source ↗

Summary

Clinical trial update for a Phase 3 study evaluating interferon alfa in newly diagnosed chronic myeloid leukemia; no efficacy results are provided in the summar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Interferon Alfa (interferon alfa)

Snippet

Sponsor: Medical Research Council | Conditions: Leukemia | Phase 3 | Status: UNKNOWN